Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
101.14
+2.22 (2.24%)
At close: Apr 24, 2025, 4:00 PM
100.75
-0.39 (-0.39%)
Pre-market: Apr 25, 2025, 7:59 AM EDT
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of $149.59 billion as of April 25, 2025. Its market cap has increased by 48.44% in one year.
Market Cap
149.59B
Enterprise Value
160.41B
1-Year Change
48.44%
Ranking
Category
Stock Price
$101.14
Market Cap Chart
Since December 1, 1998, Boston Scientific's market cap has increased from $10.63B to $149.59B, an increase of 1,306.96%. That is a compound annual growth rate of 10.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2025 | 145.98B | 10.89% |
Dec 31, 2024 | 131.64B | 55.44% |
Dec 29, 2023 | 84.69B | 27.79% |
Dec 30, 2022 | 66.27B | 9.48% |
Dec 31, 2021 | 60.53B | 17.59% |
Dec 31, 2020 | 51.48B | -18.33% |
Dec 31, 2019 | 63.03B | 28.88% |
Dec 31, 2018 | 48.90B | 43.66% |
Dec 29, 2017 | 34.04B | 15.58% |
Dec 30, 2016 | 29.45B | 18.74% |
Dec 31, 2015 | 24.81B | 41.13% |
Dec 31, 2014 | 17.58B | 9.51% |
Dec 31, 2013 | 16.05B | 104.00% |
Dec 31, 2012 | 7.87B | -0.56% |
Dec 30, 2011 | 7.91B | -31.25% |
Dec 31, 2010 | 11.51B | -15.35% |
Dec 31, 2009 | 13.59B | 16.97% |
Dec 31, 2008 | 11.62B | -32.97% |
Dec 31, 2007 | 17.34B | -31.53% |
Dec 29, 2006 | 25.32B | 26.18% |
Dec 30, 2005 | 20.07B | -33.15% |
Dec 31, 2004 | 30.02B | -0.30% |
Dec 31, 2003 | 30.11B | 73.64% |
Dec 31, 2002 | 17.34B | 78.25% |
Dec 31, 2001 | 9.73B | 75.34% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 769.21B |
UnitedHealth Group | 386.81B |
Johnson & Johnson | 371.43B |
AbbVie | 318.77B |
Novo Nordisk | 276.62B |
Abbott Laboratories | 225.29B |
AstraZeneca | 213.42B |
Novartis AG | 208.99B |